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Regular Dark Chocolate Consumption’s Reduction 
of Oxidative Stress and Increase of Free-Fatty-Acid 
Mobilization in Response to Prolonged Cycling
Judith Allgrove, Emily Farrell, Michael Gleeson, Gary Williamson, and Karen Cooper
This study investigated the effects of regular consumption of dark chocolate (DC), rich in cocoa polyphenols, 
on plasma metabolites, hormones, and markers of oxidative stress after prolonged exhaustive exercise. Twenty 
active men cycled at 60% maximal oxygen uptake (VO2max) for 1.5 hr, with the intensity increased to 90% 
VO2max for a 30-s period every 10 min, followed by a ride to exhaustion at 90% VO2max. In the 2 wk before 
exercise participants consumed 40 g of DC or an isocarbohydrate-fat control cocoa liquor–free chocolate 
(CON) twice daily and once 2 hr before exercise in a randomized, counterbalanced, crossover design. Venous 
blood samples were taken immediately before exercise, postexercise (fixed duration), postexhaustion, and 
after 1 hr of recovery. F2-isoprostanes were significantly lower (post hoc tests: p < .001) at exhaustion and 
after 1 hr of recovery with DC. Oxidized low-density lipoproteins were significantly lower with DC (p < .001) 
both before and after exercise and at exhaustion. DC was also associated with ~21% greater rises in free fatty 
acids during exercise (main effect: p < .05). Changes in circulating glucose, insulin, glucagon, cortisol, and 
interleukin (IL)-6, IL-10, and IL-1ra were unaffected by treatment. Time to exhaustion at 90% VO2max was not 
significantly different between trials (398 ± 204 and 374 ± 194 s for DC and CON, respectively). These results 
suggest that regular DC intake is associated with reduced oxidative-stress markers and increased mobilization 
of free fatty acids after exercise but has no observed effect on exercise performance.
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Physical activity results in increased production of 
free radicals and other reactive oxygen species (ROS), pri-
marily arising from elevated oxidative phosphorylation in 
the mitochondria of contracting skeletal muscle (Davies, 
Quintanilha, Brooks, & Packer, 1982; Jackson, Pyne, & 
Palomero, 2007). Other potential sources include plasma, 
blood cells such as erythrocytes and leukocytes, smooth-
muscle cells, and endothelial cells (Nikolaidis & Jamur-
tas, 2009). ROS can induce lipid and protein peroxidation, 
leading to oxidative stress, acute-phase inflammatory 
responses, and possible acceleration of muscle-fatigue 
development (Powers, Deruisseau, Quindry, & Hamilton, 
2004). Muscle cells can be protected from these ROS by 
a cooperative system of endogenous defense mechanisms 
in which antioxidants may play a role.
Supplementation with antioxidants has been proven 
effective in a number of studies at reducing the magnitude 
of the oxidative stress and inflammatory response that 
can occur after prolonged intense exercise, as well as 
limiting the degree of immunosuppression, although a 
large part of that research was limited to vitamins C and 
E (Peake, Suzuki, & Coombes, 2007; Powers et al., 2004). 
Prolonged (4 weeks) supplementation with a combina-
tion of vitamin C and vitamin E attenuated the increase 
in F2-isoprostanes (a marker of lipid peroxidation) and 
was associated with a lower plasma interleukin-6 (IL-6) 
and cortisol response to prolonged exercise (Fischer et al., 
2004). Furthermore, Davison and Gleeson (2007) demon-
strated that acute vitamin C supplementation is associated 
with a reduction in the magnitude of exercise-induced 
neutrophil-function depression. However, to date, evi-
dence to show that antioxidant supplementation can 
improve exercise performance and delay fatigue is still 
limited (Davis, Carlstedt, Chen, Carmichael, & Murphy, 
2010; McKenna et al., 2006; Medved et al., 2004).
There has been growing interest in recent research 
in the potential beneficial effects of cocoa because of 
the potent antioxidant properties of its constituent poly-
phenols. In two studies, when a high-phenolic-content 
antioxidant beverage (Morillas-Ruiz et al., 2005) or a 
polyphenol-containing sports drink (Morillas-Ruiz, Ville-
gas Garcia, Lopez, Vidal-Guevara, & Zafrilla, 2006) was 
consumed shortly before 15 min of submaximal aerobic 
exercise, the magnitude of exercise-induced oxidative 
stress was significantly reduced. Furthermore, short-term 
consumption of black currant extract, abundant in poly-
phenols, reduced exercise-induced oxidative stress and 
inflammatory responses (lipopolysaccharide inflamma-
2  Allgrove et al.
tory responses) to 30 min of rowing (Lyall et al., 2009), 
and green tea extract consumed acutely has been shown to 
stimulate lipid catabolism and increase fat oxidation after 
30 min of cycling (Venables, Hulston, Cox, & Jeukend-
rup, 2008). More recently, 7 days supplementation with 
quercetin, a natural polyphenol flavonoid, was reported 
to increase endurance capacity in untrained participants, 
possibly via increased mitochondrial biogenesis (Davis 
et al., 2010). Dark chocolate is one of the richest dietary 
sources of antioxidant polyphenols. Cocoa polyphenols, 
most notably the monomers catechin and epicatechin, 
can exist in both lipid- and water-based environments 
(amphipathic), meaning they can spare both lipophilic 
and hydrophilic vitamins. Studies have shown beneficial 
effects of chronic cocoa or dark chocolate consumption 
(Cooper, Donovan, Waterhouse, & Williamson, 2008) in 
healthy participants (usually ~100 g of dark chocolate 
per day for 2 weeks or more) on arterial and endothelial 
function (Vlachopoulos et al., 2005), resting blood pres-
sure and insulin sensitivity (Grassi, Lippi, Necozione, 
Desideri, & Ferri, 2005), or cholesterol profile (increased 
high-density lipoprotein [HDL] concentration; Mursu et 
al., 2004). However, there have been few studies investi-
gating the potential of cocoa-containing foods to modu-
late exercise-induced oxidative stress and performance. 
Dark chocolate also contains caffeine and theobromine, 
which may also have potential ergogenic effects. Caf-
feine ingestion has been shown to increase fatty-acid 
mobilization from stores and spare glycogen while also 
stimulating the central nervous system and increasing 
muscle excitability, resulting in enhanced performance 
(Burke, 2008). Theobromine may also increase free-fatty-
acid mobilization, although its effects during exercise are 
unclear (Eteng & Ettarh, 2000).
There is limited information on the effects of 
ingesting dark chocolate, rich in cocoa polyphenols, 
on oxidative stress and immunoendocrine responses 
after prolonged (>1.5 hr duration) exercise and how this 
relates to exercise performance. Therefore, the aims of 
the current study were to examine the effects of a 2-week 
period of regular dark chocolate consumption on the 
responses of selected plasma markers of oxidative stress, 
hormones, and cytokines to a single bout of prolonged 
exhaustive exercise.
Methods
Participants
After we received university ethical committee approval, 
20 healthy men (age 22 ± 4 years, body mass 74.6 ± 8 kg, 
maximal oxygen uptake [VO2max] 53.1 ± 7.0 ml · kg–1 · 
min–1, power output at VO2max 300 ± 30 W; M ± SD) partici-
pated in the study. They were all familiar with cycling and 
actively engaged in regular physical activity for a minimum 
of 2 hr, three times per week, as determined by a physical 
activity and health questionnaire. They were informed of 
the experimental procedures (written and verbally) before 
signing consent forms. Participants meeting one or more 
of the following criteria were excluded from the study: 
smoking, regular consumption of dark chocolate or similar 
high-polyphenol products or vitamin supplements, any 
sports supplements, medication, and alcohol. All partici-
pants completed four exercise bouts: two preliminary trials 
(VO2max determination and familiarization) and two main 
trials. Trials were separated by 1 week, and there was a 
2-week washout period between the main trials.
Design and Protocol
Preliminary Measurements. Participants completed 
a continuous incremental exercise test to volitional 
exhaustion on an electronically braked cycle ergometer 
(Lode Excalibur, Holland). After a 3-min warm-up at 
95 W they cycled with 35-W increments every 3 min 
until volitional exhaustion. Expired-gas samples were 
collected in Douglas bags during the final minute of 
each stage. Heart rate (Polar A1, Polar Electro, Kempele, 
Finland) and rating of perceived exertion (Borg scale) 
were collected during this period. The expired gas 
was analyzed by an oxygen–carbon dioxide analyzer 
(Servomex 1400, Crowbridge, UK), and volume was 
measured by a dry gas meter (Harvard Apparatus, 
Edenbridge, UK) to determine ventilation, oxygen 
uptake, and carbon dioxide production. From the VO2–
work rate relationship, the work rates equivalent to 60% 
and 90% VO2max were interpolated. On a second occasion 
participants completed a familiarization ride. The purpose 
of this was to familiarize them with the exercise protocol 
and to check that the correct relative intensity exercise 
was being performed. Participants cycled for 1.5 hr at a 
work rate equivalent to 60% VO2max, and every 10 min 
the exercise intensity was increased to 90% VO2max for 
30 s. Expired-gas samples were collected over a 1-min 
period into Douglas bags after 10 min and 30 min of 
exercise and then every 30 min thereafter; heart rate and 
rating of perceived exertion were measured every 15 min.
Main Trials. For the main trials, participants exercised 
under two different conditions—a DC (dark chocolate) 
trial or CON (control cocoa liquor–free chocolate) 
trial—in a single-blind, randomized, and counterbalanced 
design. They arrived at the laboratory at 9:30 a.m. on the 
days of the main trials after an overnight fast (>10 hr) 
followed by a breakfast at 8 a.m. that had consisted of 
chocolate (40 g DC or 30.4 g isocaloric CON) and 500 ml 
water only. On arrival, participants were asked to empty 
their bladder, after which body mass was measured in 
minimal clothing. The exercise bouts began at 10 a.m. 
Water (2.5 ml/kg body mass) was consumed at the onset, 
every 15 min during, and on completion of the exercise 
bout. Exercise consisted of steady-state cycling at 60% 
VO2max for 1.5 hr; every 10 min the exercise intensity 
was increased to 90% VO2max for 30 s. The exercise 
protocol was chosen to simulate a race situation with 
occasional bursts of higher intensity work while still 
having a standardized exercise protocol. It also served 
to familiarize the subjects with the effort required to 
exercise at 90% VO2max before they performed the ride 
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to exhaustion at the end of the trial. At the end of the 
1.5 hr of exercise, subjects were given a 5-min break, 
immediately followed by a time-to-exhaustion trial (at 
90% VO2max). They were instructed to maintain a pedal 
cadence of more than 50 rpm while cycling, to remain 
seated at all times, and to attempt to cycle for as long as 
possible. No external encouragement was given during 
the trial, and no information about elapsed time was 
given during the ride to exhaustion. Expired gas was 
collected into Douglas bags (1-min sample) during the 
25th, 55th, and 75th minutes of exercise, for analysis of 
VO2 and respiratory-exchange ratio (RER). Heart rate and 
rating of perceived exertion were recorded after 15 min 
of exercise and every 10 min thereafter. Heart rate alone 
was recorded unobtrusively every 5 min during the ride 
to exhaustion. After completion of the exhaustion trial, 
participants were weighed again.
Venous blood samples were taken at rest immediately 
before exercise (Pre-Ex), immediately after completing the 
1.5-hr exercise bout (Post-Ex), immediately after complet-
ing an exercise bout to exhaustion (Post-Exh), and after 
1 hr of resting recovery (1 hr Post-Exh). On each occa-
sion 25 ml blood was obtained from an antecubital vein 
with a 21-g butterfly needle and syringe. Blood was then 
dispensed into five Vacutainer tubes (Becton Dickinson, 
Oxford, UK), four K3EDTA tubes, and one heparin tube.
Participants completed a food diary for the 48 hr 
before the first trial (familiarization) and were required 
to follow the same diet during the 48 hr before each 
main trial. They were required to abstain from alcohol, 
caffeine, polyphenol-containing products (other than the 
prescribed chocolate), and heavy exercise for 48 hr before 
each trial and to have a rest day on the day immediately 
before each trial. It was also stipulated that participants 
should not take any mineral or vitamin supplement or 
any other antioxidant supplements during and for the 
4 weeks before the study. They were provided with a 
food-exclusion list to ensure that they avoided high-
polyphenol- and -caffeine-containing foods for the 48 
hr before each main trial.
Treatments
Participants consumed the total daily amount of pre-
scribed chocolate (80 g for DC, 56.8 g for CON) in two 
equal portions with their breakfast and evening meals 
every day for 2 weeks. They also consumed a portion 
of the same chocolate on the day of the main trials. To 
prevent changes in daily energy intake, participants were 
asked to replace their normal snacks (e.g., cookies, candy) 
or desserts with the chocolate but not to reduce their 
intake of fruit and vegetables.
The dark chocolate was 40.0 g Nestlé Noir™ 70% 
chocolate containing cocoa liquor, sugar, cocoa butter, 
milk fat, lecithin, and vanilla. The control chocolate (30.4 
g, which was 71% of the mass of the DC) was matched 
in terms of fat (18%) and carbohydrate (77%) content 
and total energy (2.1 MJ) and contained all the same 
ingredients except the cocoa liquor (0%). (See Table 1 
for more detailed composition.)
Blood Analysis
K3EDTA blood was used for hematological analysis 
including hemoglobin, hematocrit, and total and differ-
ential leukocyte counts using an automated hematology 
analyzer (AC•T 5diff analyzer, Beckman Coulter, UK). 
Plasma volume changes were calculated according to 
Dill and Costill (1974). The remaining K3EDTA and 
heparinized whole blood was spun at 1,500 g for 10 
min in a refrigerated centrifuge at 4 °C within 10 min of 
sampling. The plasma obtained was immediately stored 
at –80 °C until analysis. K3EDTA plasma was used 
to determine changes in the plasma concentrations of 
selected metabolites, hormones, cytokines, and markers 
of oxidative stress. Heparinized plasma was used for the 
analysis of triglycerides, vitamin C, uric acid, and total 
antioxidant capacity.
Plasma Antioxidants. Plasma Trolox-equivalent 
antioxidant capacity (TEAC) was determined using an 
automated analyzer (Cobas-Mira Plus, Roche, Basle, 
Switzerland) and a commercially available kit (Randox, 
County Antrim, UK) for measuring the capacity of plasma 
to scavenge the 2,2′-azinobis-(3-ethylbenzothiazoline-
6-sulphonic acid) radical cation. Trolox was used as 
the standard, so this measure of total antioxidant status 
was expressed in Trolox-equivalent antioxidant units 
(mM). Plasma vitamin C concentration was determined 
according to Liu, Chin, Kiser, and Bigler (1982) using 
a specific spectrophotometric ascorbate oxidase (E 
1.10.3.3) assay. Plasma uric acid concentration was 
determined according to a spectrophotometric method 
using a commercially available kit (Randox, County 
Antrim, UK).
Table 1 Chocolate Composition
DC 
(absolute 
amount 
per 40 g)
CON 
(absolute 
amount 
per 40 g)
CON 
(absolute 
amount per 
30.4 g)
Ash (g) 0.84 0.0 0.0
Protein (g) 2.84 0.0 0.0
Fat (OICC; g) 17.4 25.1 17.8
Fiber (g) 4.3 <0.2 <0.2
Energy (kJ) 932 1,182 839
Sucrose (g) 10.3 14.6 10.4
Caffeine (mg) 41.6 9.6 6.8
Theobromine (g) 267 6.4 4.5
Polyphenols (mg)
 catechin 15.6 0 0
 epicatechin 38.7 0 0
 Dimer B2 23.4 0 0
 Dimer B5 2.9 0 0
 Trimer C 13.9 0 0
 Tetramer D 4.2 0 0
Note. DC = dark chocolate; CON = control.
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Plasma Markers of Oxidative Stress. Plasma free 
F2-isoprostane concentration and the plasma concentrations 
of oxidized low-density lipids (LDLs) were determined 
using commercially available ELISA kits according to 
the manufacturer’s instructions (Cayman Chemical Co., 
Ann Arbor, MI, and Mercodia AB, Uppsala, Sweden, 
respectively).
Plasma Hormone and Cytokine Concentrations. Com-
mercially available ELISA kits were used to determine 
the concentrations of cortisol (DRG Diagnostics, 
Marburg/Lahn, Germany), adrenocorticotropic hormone 
(Biomercia, Irvine, CA), insulin (ultrasensitive kit, DRG 
Diagnostics), glucagon (Cosmobio, Japan), IL-10 (high-
sensitivity kit, Diaclone, Besançon, France), IL-1ra (R&D 
systems, Minneapolis, MN), and IL-6 (high-sensitivity 
kit, Diaclone).
Plasma Metabolite Concentrations. Plasma glucose 
concentration was determined on an automated analyzer 
(Cobas Mira Plus, Roche, Basel, Switzerland) using 
a colorimetric glucose oxidase PAP kit (Randox, 
County Antrim, UK). Plasma lactate concentration was 
determined on a spectrophotometer at 340 nm using a 
standard enzymatic assay with lactate dehydrogenase 
and nicotinamide adenine dinucleotide (Sigma, Poole, 
UK). Analysis of free fatty acids (FFAs) was performed 
using the Wako 999–75406 NEFA-C kit, and triglyceride 
analysis was performed using the triglyceride Infinity 
reagent kit (Alpha Laboratories, Eastleigh, UK).
Data Analysis
Data are presented as means and standard deviations. To 
compare the two different trials, DC and CON, a two-
way repeated-measures ANOVA (Trial × Time) was used. 
Data that were not normally distributed were normalized 
with log transformation. Post hoc analysis was carried 
out, when appropriate, using paired-samples t tests with 
the Holm–Bonferroni correction. When the two-way 
ANOVA showed a significant Trial × Time interaction 
(indicating different temporal responses depending on 
trial), one-way repeated-measures ANOVA was also 
used to determine the temporal response in each trial 
independently. The Greenhouse–Geisser correction was 
applied to all ANOVA p values.
Results
The effects of DC on the physiological demands of exer-
cise are presented in Table 2. There were no significant 
differences between trials in overall exercise intensity 
during the steady-state exercise. Mean heart rates were 
similar between the two conditions, as were mean ratings 
of perceived exertion. RER did not differ significantly 
between trials (p = .08). Times to exhaustion at 90% 
VO2max were 398 ± 204 and 374 ± 194 s for the DC and 
CON trials, respectively. There was no significant differ-
ence between treatments.
Markers of Antioxidant Capacity
Plasma uric acid concentration increased Post-Exh and 
1 hr Post-Exh compared with Preex in both trials (main 
effect of time, p < .001). Vitamin C increased with time 
in both trials (main effect of time, p < .001). Total antioxi-
dant status was higher Post-Exh than Pre-Ex (main effect 
of time, p < .001). These temporal responses were not 
significantly influenced by DC supplementation (Table 3).
Markers of Oxidative Stress
There was a significant main Trial × Time interaction 
effect (p = .045) and main effect of time (p < .01) and 
trial (p < .001) for plasma free F2-isoprostane concentra-
Table 2 Heart Rate, Rating of Perceived Exertion, Percent of Maximal Oxygen Uptake, and 
Respiratory-Exchange Ratio During Exercise, M (SD)
25 min 55 min 75 min
Main-effects p values, trial; 
time; Trial × Timea
Heart rate (beats/min) >.1; <.001; >.1
 dark chocolate trial 144 (11) 152 (13) 155 (12)
 control trial 145 (10) 149 (12) 152 (10)
Rating of perceived exertion >.1; <.001; >.1
 dark chocolate trial 11 (1) 12 (1) 12 (1)
 control trial 10 (1) 12 (1) 12 (1)
Percent of maximal oxygen 
uptake >.1; <.001; >.1
 dark chocolate trial 62.5 (4.1) 64.5 (4.1) 65.0 (4.9)
 control trial 61.5 (6.3) 63.2 (6.4) 64.6 (6.8)
Respiratory-exchange ratio .08; <.001; >.1
 dark chocolate trial 0.90 (0.05) 0.88 (0.04) 0.87 (0.04)
 control trial 0.92 (0.03) 0.90 (0.04) 0.90 (0.03)
aResults from two-way ANOVA.
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tion. Values increased Post-Exh in both CON (p < .001) 
and DC (p < .001) but were significantly lower in DC 
at Post-Exh (p < .001) and 1 hr Post-Exh (p < .05) than 
in CON (Figure 1). There was a significant main Trial × 
Time interaction effect (p = .027) and main effect of time 
(p < .001) and trial (p = .001) for plasma oxidized LDLs 
(Figure 2). Values were significantly lower in DC at Pre-
Ex, Post-Ex, and Post-Exh (all p < .001) than in CON.
Plasma Hormones
Plasma insulin concentration decreased Post-Ex (main 
effect of time, p < .001), plasma glucagon increased 
Post-Ex (main effect of time, p < .001), and adrenocor-
ticotropic hormone concentration increased Post-Ex and 
Post-Exh (main effect of time, p < .001) compared with 
Pre-Ex. The overall temporal responses on these values 
were the same between trials (Table 4). Plasma cortisol 
concentration was not significantly affected by exercise 
or by trial (Table 4).
Plasma Metabolites
Plasma glucose concentration decreased at 1 hr Post-Exh 
compared with Pre-Ex (main effect of time, p < .001), 
and plasma lactate concentration increased Post-Ex and 
Post-Exh (main effect of time, p < .001). The temporal 
responses were not different between trials (Table 5). 
Plasma FFA concentration increased Post-Ex and Post-
Exh compared with Pre-Ex in both trials. There was also 
a significant main effect of trial (p = .038), with higher 
FFA levels in DC than in CON (Figure 3). Plasma triglyc-
Table 3 Markers of Antioxidant Status Before and After Exercise, M (SD)
Pre-Ex Post-Ex Post-Exh 1 hr Post-Exh
Main-effects p values, 
trial; time; Trial × Timea
Vitamin C (μM) >.1; <.001; >.1
 dark chocolate trial 54.8 (5.0) 58.3 (5.7) 62.9 (5.6) 61.9 (5.9)
 control trial 54.2 (6.1) 56.7 (6.8) 61.8 (6.2) 62.3 (5.6)
Uric acid (μM) >.1; <.001; >.1
 dark chocolate trial 352 (63) 375 (73) 417 (110) 424 (83)
 control trial 345 (55) 351 (53) 407 (80) 400 (72)
Total antioxidant status (mM) .07; <.001; >.1
 dark chocolate trial 1.45 (0.09) 1.54 (0.14) 1.62 (0.15) 1.50 (0.11)
 control trial 1.35 (0.30) 1.48 (0.06) 1.58 (0.20) 1.45 (0.14)
Note. Ex = exercise; Exh = exhaustion.
aResults from two-way ANOVA.
Figure 1 — F2-isoprostane levels before and after exercise, M (SD). DC = dark chocolate; CON = control; Pre-Ex = preexercise; 
Post-Ex = postexercise; Post-Exh = postexhaustion. *Significantly different from CON, p < .05. **Significantly different from CON, 
p < .001. #Significantly higher than resting values within trial, p < .05. ##Significantly higher than resting values within trial, p < .001.
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erides were higher at Post-Ex and Post-Exh than Pre-Ex 
on both trials (main effect of time, p < .001) but did not 
differ significantly between trials (Figure 4).
Circulating Leukocytes and Cytokines
Circulating leukocyte count (p = .001), neutrophil count 
(p < .001), plasma IL-6 concentration (p < .001), and 
IL-10 concentration (p < .001) all increased after exercise 
and remained elevated throughout the exercise protocol 
(Table 6). However, these temporal patterns did not differ 
between trials. Plasma IL-1ra (Table 6) was elevated at 
Post-Exh and 1 hr Post-Exh compared with Pre-Ex (main 
effect of time, p < .001), with no difference between trials.
Discussion
The main findings of the study were that chronic con-
sumption of DC daily for 2 weeks before an acute bout 
of prolonged exhaustive exercise resulted in lower resting 
and postexercise plasma levels of the oxidative stress 
markers F2-isoprostanes and oxidized LDL but had no 
effect on cytokine responses. Dark chocolate inges-
tion was associated with greater rises in plasma FFA 
during exercise and a tendency for a lower RER (sug-
gesting a higher contribution of fat oxidation to energy 
expenditure). However, regular consumption of DC had 
no significant effect on time to fatigue compared with 
isocarbohydrate-fat control.
Figure 2 — Oxidized low-density-lipid (LDL) levels before and after exercise, M (SD). DC = dark chocolate; CON = control; 
Pre-Ex = preexercise; Post-Ex = postexercise; Post-Exh = postexhaustion. *Significantly different from CON, p < .001. #Significantly 
higher than resting values within trial, p < .05. ##Significantly higher than resting values within trial, p < .001.
Table 4 Circulating Hormones Before and After Exercise, M (SD)
Pre-Ex Post-Ex Post-Exh 1 hr Post-Exh
Main-effects p values, trial; 
time; Trial × Timea
Insulin (mU/L) >.1; <.001; .071
 dark chocolate trial 7.3 (4.0) 4.3 (4.2) 3.6 (4.3) 1.8 (1.3)
 control trial 4.9 (3.5) 2.6 (2.2) 3.4 (3.1) 1.6 (1.2)
Glucagon (pg/ml) >.1; <.001; >.1
 dark chocolate trial 337 (190) 411 (249) 415 (237) 352 (207)
 control trial 356 (261) 402 (200) 432 (277) 359 (206)
Adrenocorticotropic 
hormone (pg/ml) >.1; <.001; >.1
 dark chocolate trial 34.1 (21.2) 62.0 (41.8) 88.4 (59.4) 22.9 (15.4)
 control trial 35.4 (27.8) 60.9 (37.5) 88.0 (44.6) 19.4 (11.3)
Cortisol (nM) >.1; .094; >.1
 dark chocolate trial 365 (103) 377 (136) 391 (137) 359 (109)
 control trial 370 (94) 406 (123) 422 (109) 351 (94)
Note. Ex = exercise; Exh = exhaustion. 
aResults from two-way ANOVA.
7Table 5 Circulating Glucose and Lactate Before and After Exercise, M (SD)
Pre-Ex Post-Ex Post-Exh 1 hr Post-Exh
Main-effects p values, trial; 
time; Trial × Timea
Glucose (mM) >.1; <.001; >.1
 dark chocolate trial 4.97 (0.50) 4.82 (0.78) 4.85 (0.90) 4.53 (0.78)
 control trial 5.05 (0.40) 4.84 (0.52) 5.06 (0.92) 4.58 (0.44)
Lactate (mM) >.1; <.001; >.1
 dark chocolate trial 1.2 (0.3) 3.1 (1.2) 8.2 (1.7) 1.2 (0.4)
 control trial 1.2 (0.2) 3.3 (1.1) 8.1 (1.8) 1.2 (0.3)
Note. Ex = exercise; Exh = exhaustion. 
aResults from two-way ANOVA.
Figure 4 — Triglyceride concentration before and after exercise, M (SD). DC = dark chocolate; CON = control; Pre-Ex = preex-
ercise; Post-Ex = postexercise; Post-Exh = postexhaustion.
Figure 3 — Free-fatty-acid (FFA) concentration before and after exercise, M (SD). Significant main effect of trial, p = .038. DC = 
dark chocolate; CON = control; Pre-Ex = preexercise; Post-Ex = postexercise; Post-Exh = postexhaustion.
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The current results show a blunting of the oxidative-
stress marker F2-isoprostane in response to prolonged 
exercise with DC consumption. F2-isoprostane is consid-
ered a reliable and sensitive marker of lipid peroxidation 
(Roberts & Morrow, 2000). These findings are in line with 
those of Wiswedel et al. (2004), who observed a lower 
level of plasma F2-isoprostane after a high-flavanol (187 
mg flavanols/100 ml) cocoa drink than with a low-flavanol 
cocoa drink (14 mg flavanols/100 ml). However, they 
observed no effect of exercise on oxidative stress, which 
was most likely because of the relatively short duration 
of the exercise bout (29 min). Furthermore, a lower 
F2-isoprostane response has been observed with vitamin 
C and E consumption after 3 hr of knee-extensor exercise 
at 50% of maximal power output (Fischer et al., 2004) 
and after a 50-km ultramarathon (Mastaloudis, Morrow, 
Hopkins, Devaraj, & Traber, 2004). In the current study, 
the reduced F2-isoprostane response with DC consump-
tion was paralleled by lower levels of oxidized LDL. 
Decreased rates of ex vivo LDL oxidation have been 
shown after consumption at rest of flavanol-rich choco-
late (Osakabe et al., 2001; Wan et al., 2001). Although 
these results indicate a chronic effect of DC on oxidative 
stress both at rest and in response to exercise, one cannot 
exclude a possible acute effect of the 40 g of DC ingested 
2 hr before exercise.
DC resulted in an increase in FFA concentration 
postexercise, indicating an increase in adipocyte lipoly-
sis. These effects most likely occur via the inhibition of 
catechol O-methyltransferase, an enzyme that degrades 
noradrenaline, which may prolong adrenergic drive and 
increase lipolysis (Dulloo et al., 1999).Venables et al. 
(2008) demonstrated that three capsules of green tea (890 
mg polyphenols and 366 mg epigallocatechin gallate) 
ingested in the 24-hr period before 30 min of exercise 
at 60% VO2max resulted in higher levels of plasma FFA 
with a concomitant increase in fat oxidation. RER values 
measured during exercise tended to be lower with DC in 
the current study, suggesting an increase in fat oxidation 
to energy expenditure. However, because FFA concen-
tration was only measured in the postexercise period, a 
direct comparison between these two parameters cannot 
be made. An increase in FFA mobilization during pro-
longed exercise after dark chocolate consumption could 
be viewed as beneficial to those who may be exercising 
as part of a weight-loss program, in addition to athletes 
attempting to conserve carbohydrate stores. It is worth 
noting that both caffeine and theobromine can indepen-
dently promote lipolysis and increase FFA concentration 
(Durham, Miller, Lindeman, & Lapachet, 1993). Fur-
thermore, catechins are suggested to act synergistically 
with caffeine to enhance fat oxidation (Dulloo, Seydoux, 
Girardier, Chantre, & Vandermander, 2000). Because 
the DC contained low levels of caffeine (41.6 mg) and 
theobromine (267 mg) that were ingested 2 hr before 
exercise, it is not possible to determine whether caffeine, 
theobromine, or polyphenol content, either in isolation 
or in combination, was responsible for the effect on FFA.
Previous studies have shown enhanced antioxidant 
capacity after DC consumption (Rein et al., 2000; Serafini 
et al., 2003; Wang et al., 2000). Several components 
of plasma contribute to plasma TEAC. Albumin and 
uric acid are thought to account for two thirds of the 
plasma TEAC. Many proteins such as ceruloplasmin 
and transferrin and small antioxidant molecules such as 
nonprotein thiols and vitamins C and E account for the 
remainder of the plasma TEAC. Ingestion of polyphenol-
containing foods could raise the plasma polyphenol 
Table 6 Circulating Leukocyte Counts and Plasma Cytokines Before and After Exercise, M (SD)
Pre-Ex Post-Ex Post-Exh 1 hr Post-Exh
Main-effects p values, trial; 
time; Trial × Timea
Leukocyte count (× 109/L) >.1; <.001; >.1
 dark chocolate trial 5.8 (1.6) 10.9 (3.9) 13.8 (5.0) 11.4 (4.4)
 control trial 5.5 (1.6) 10.3 (3.7) 13.2 (4.3) 11.3 (3.4)
Neutrophil count (× 109/L) >.1; <.001; >.1
 dark chocolate trial 2.8 (1.2) 6.6 (3.3) 8.3 (4.1) 8.8 (3.9)
 control trial 2.7 (0.9) 6.3 (2.7) 7.9 (3.3) 8.8 (3.0)
IL-6 (pg/ml) >.1; <.001; >.1
 dark chocolate trial 1.7 (2.3) 3.0 (2.1) 3.9 (1.8) 2.7 (2.2)
 control trial 1.8 (2.2) 3.2 (2.4) 4.2 (2.7) 2.7 (2.0)
IL-10 (pg/ml) >.1; .031; .053
 dark chocolate trial 1.9 (1.7) 2.7 (1.5) 2.8 (1.9) 3.7 (2.7)
 control trial 1.8 (1.2) 2.3 (1.2) 2.9 (1.5) 2.5 (1.9)
IL-1ra (pg/ml) >.1; <.001; >.1
 dark chocolate trial 320 (180) 402 (187) 502 (220) 1067 (895)
 control trial 267 (75) 348 (115) 438 (170) 1081 (845)
Note. Ex = exercise; Exh = exhaustion. 
aResults from two-way ANOVA.
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content, although this may not be enough to affect the 
TEAC value because of the overwhelming contribution 
of the other plasma components. However, ingestion of 
polyphenols or indeed other components in the chocolate 
may affect the TEAC through changes in the endogenous 
plasma components. This may explain the lack of signifi-
cant difference in plasma antioxidant capacity between 
treatments observed in the current study. Furthermore, 
the physiological relevance of these tests in plasma is 
currently controversial (Sies, 2007).
There are currently limited data in human studies 
to suggest that antioxidant supplementation enhances 
exercise performance through preventing oxidative 
mechanisms and muscle fatigue (Powers et al., 2004). 
N-acetylcysteine supplementation acutely (<1 hr) before 
exercise and during exercise delayed time to fatigue by 
~24% at 91% VO2max after 45 min submaximal cycling 
at 71% VO2max (McKenna et al. 2006), and 7 days of 
quercetin supplementation increased VO2max (~3.9%) 
and cycling time (~13.2%) to fatigue at 75% VO2max in 
untrained participants (Davis et al., 2010). There was 
no significant effect of dietary DC intake on exercise 
performance in the current study. In fact, some evidence 
suggests that antioxidant supplementation may inhibit 
some of the exercise-induced cellular signaling that 
up-regulates adaptations in vascular tissue and skeletal 
muscle (Sen, 2001), which may limit exercise perfor-
mance (Malm, Svensson, Ekblom, & Sjodin, 1997; Peake 
et al., 2007).
Chronic daily ingestion of vitamin C or combined 
vitamin C and E supplements over several weeks have 
been shown to decrease the IL-6 and cortisol responses to 
prolonged exercise (Fischer et al., 2004; Vassilakopoulos 
et al., 2003). However, Nieman et al. (2004) reported no 
effect of daily vitamin E supplements over 2 months on 
cortisol and IL-6 compared with placebo after a com-
petitive triathlon event. Furthermore, Mastaloudis et al. 
(2004) found no effect of 6 weeks of vitamin C and E 
supplementation on IL-6 after a 50-km ultramarathon, 
despite preventing increases in plasma lipid peroxida-
tion. In the current study chronic consumption of DC 
had no effect on plasma adrenocorticotropic hormone, 
cortisol, IL-6, or IL-1ra concentrations after prolonged 
exercise, and in line with Mastaloudis et al., this indicates 
that oxidative damage and the inflammatory response to 
exercise operate independently (Nieman et al., 2002).
Oxidative stress has been implicated in the depres-
sion of immune-cell function that typically occurs 
after prolonged exercise, the magnitude of which may 
be decreased with appropriate preexercise antioxidant 
supplementation (Davison & Gleeson, 2006; Lee & Wan, 
2000; Robson, Bouic, & Myburgh, 2003). However, 
there was no significant effect of DC consumption on 
circulating leukocyte or neutrophil numbers at rest or in 
response to exercise. Leukocytosis is influenced by both 
cortisol and some cytokines (IL-6), and because there 
was no effect of DC consumption on these responses in 
the current study, it is perhaps not surprising that there 
was no effect on neutrophil numbers. The finding of a 
reduction in oxidative-stress markers with DC with no 
effect on leukocytes also suggests that these effects are 
a result of a direct “antioxidant” effect and not via other 
indirect mechanisms occurring in blood.
In conclusion, the current study demonstrates that 
DC consumption daily for 2 weeks and 2 hr before 
prolonged exercise has significant effects on oxidative-
stress markers and the temporal response of plasma FFA. 
However, there were no effects on the plasma concen-
tration of measured hormones, cytokines, or circulating 
numbers of total leukocytes and neutrophils or on exercise 
performance.
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